Follow us on:
Phage Display Platform
Creative Biolabs develops and commercializes a full range of integrated innovative services that are based on phage display technology. We have ...
Membrane Protein Platform
Creative Biolabs has established custom membrane protein and membrane protein antibody production platforms for antibody discovery...
Hyperdoma™ Platform
Creative Biolabs has developed the novel Hyperdoma™ platform, which is a high-throughput hybridoma generation and screening platform based on the advanced ClonePix system. We ...
Creative Biolabs has established a universal antibody humanization platform to develop high affinity human monoclonal antibodies derived from non-human primates (NHPs). This platform, known as High-Affi™ human antibody platform, can offer higher affinity antibodies than humanized anti ... ------ LEARN MORE >
A single domain antibody (also called domain antibody or sdAb), is an antibody fragment consisting of a single monomeric variable antibody domain, and lacking the light chain and CH1 domain of the heavy chain. Like a whole antibody, it is able to bind selectively to a specific antigen. With a molecular weight of only 12–15 kDa, single domain antibody are much ... ------ LEARN MORE >
Creative Biolabs has extensive experience to offer the novel human or humanized antibody services for either therapeutic or laboratory applications. We have three routes in developing human antibodies. The most straightforward method is to screen our human antibody libraries; antibody discovery from transgenic mice could be the second choice; while we are also professional in offering various antibody humanization services, such as … ------ LEARN MORE >
Affinity maturation is the process to improve antibody affinity for an antigen. In vivo, natural affinity maturation by the immune system takes place by somatic hypermutation and clonal selection. In vitro, in the laboratory affinity maturation can be obtained by mutation and selection.tumor marker (e.g. a protein that, ideally, is only to be found in or on tumor cells). Antibodies track ... ------ LEARN MORE >
With experience in membrane protein and antibody research, Creative Biolabs provides world-leading production service of antibody targeting membrane protein by using Magic™ platform. Membrane proteins consist of 20~30% of all encoding genes in genome. They participate in different ... ------ LEARN MORE >
Creative Biolabs has proudly developed the unique Native™ Antibody Discovery Platform to develop native monoclonal antibodies using antigen-specific B lymphocytes cytometry technology. Current in vitro antibody display methods cannot provide antibodies with naturally paired heavy chain and light chain. For technical reasons, the natural pairings of heavy and light chains found in antibody-producing B cells are ... ------ LEARN MORE >
Creative Biolabs is a leading service provider that focuses on developing proteins and high specific, high affinity monoclonal antibodies for research, diagnostic and therapeutic use. Our service portfolio includes bio-fishing platform, epitope mapping, antibody discovery using phage display technology and a wide range of antibody gene engineering, affinity maturation and humanization services. ------ LEARN MORE >
Creative Biolabs is a leading service provider that focuses on biomacromolecules engineering for research, diagnostic and therapeutic use. Our service portfolio includes mouse and rat monoclonal antibody production using hybridoma technology, humanized antibody production using phage display technology and a wide range of antibody gene engineering, affinity maturation and humanization services. In addition, we are well-recognized in ... ------ LEARN MORE >
Creative Biolabs offers a full range of custom protein expression and bio-manufacturing services that cover gene synthesis, vector construction, pilot expression, process optimization, fermentation and protein purification. Besides, Creative Biolabs can generate your stable cell line with the best quality and best price. ------ LEARN MORE >
Subscribe to Our Newsletter for Updates:
